A Closer Look: Retail Price Maintenance Is Latest Hurdle For Multinationals In China
This article was originally published in PharmAsia News
Executive Summary
A court ruling against J&J’s medical devices arm raises another red flag for multinationals in a country where healthcare pricing has come under fire. PharmAsia News takes a closer look at the decision, and on the fines handed down Aug. 7 to infant formula makers.